Mach7 Technologies and 3D Medical Complete Merger

The merger is designed to expand the international market for the enterprise imaging and 3D printing capabilities of the company, which include 3D medical printing; EchoPixel holographic projection technology; and GestSure surgery image control.

Mach7 Technologies provides an enterprise platform that delivers complete image management with rapid record identification, integration, synchronization and routing, advanced clinical viewing, and optimized, vendor-neutral archiving. Under the terms of the merger, Mach7 Technologies will maintain its US headquarters for product development, professional services, sales and marketing, with the Australian 3DM offices in charge of expanding sales and marketing efforts throughout Australia, New Zealand, and Western Europe.

“We will remain a nimble company focused on providing the most innovative enterprise imaging platform in the world. Access to new capital will enable us to surpass business and product roadmap goals in a shorter time frame and to better serve our customers,” said Albert Liong, CEO of Mach7 Technologies Limited. “Mach7 has enjoyed substantial growth in recent years, and we feel this will be enhanced with access to the public capital market. Australian investors appreciate world leading healthcare technology, and we look forward to this new phase as we continue to build our global presence.”

“We are delighted to have secured an agreement to bring our companies together; we have enjoyed a close working relationship with Mach7 and admire their outstanding success in the USA and Asia,” said Dr. Nigel Finch, chairman of 3DM. “The transaction will drive earnings and transform the combined entity into a global operation, allowing significant opportunities to scale 3DM’s value-adding data activities to leading healthcare institutions globally.”

Related Links:
Mach7 Technologies
3D Medical